Ukraine, May 27, 2021: A medical equipment company’s Hologic logo is shown on… [+] a smartphone and a computer screen in this photo illustration. (Image courtesy of Pavlo Gonchar/SOPA Images/LightRocket/Getty Images)
Getty Images/SOPA Images/LightRocket
Hologic (NASDAQ: HOLX), a medical device company focused on women’s health, has had its stock price climb by 7% in the last twenty-one trading days, but only by 12% in the last year. Following the FDA’s approval of Hologic’s Covid-19 test last year, the company’s installed base of Panther systems has grown. With the increase in Covid-19 immunization rates, the requirement for testing will steadily reduce in the future. Hologic’s Panther systems, on the other hand, can be used for a variety of different tests and, once implemented, will provide ongoing services income for the corporation. Indeed, the company’s installed base of about 2,600 devices represents a significant 40 percent increase over pre-pandemic levels. In addition, Hologic finalized the $808 million acquisition of Mobidiag, an acute-care molecular diagnostics firm, last month, strengthening Hologic’s diagnostics services. Will HOLX stock continue to increase after a 7 percent gain in twenty-one trading days, or will it begin to fall? Based on past performance, the stock of HOLX is more likely to climb in the coming month. In the last ten years, 309 of the 511 times HOLX stock has seen a twenty-one day spike of 7% or more have resulted in HOLX stock rising over the following one month period (twenty-one trading days). This historical pattern indicates that HOLX stock will gain 309 times out of 511 times in the next month, or nearly 60% of the time. For more information, see our Hologic Stock Chances of a Rise study.
Using data from the previous 10 years, the ‘Event Probability’ and ‘Chance of Rise’ were calculated.
On 57 percent of the times when the stock moved -3.0 percent or more in a five-day period, the stock increased in the following five days.
On 58 percent of the times when the stock moved -1.9 percent or more in a ten-day period, the stock increased in the following ten days.
On 60 percent of the times when the stock moved 6.6 percent or more in a twenty-one-day period, the stock rose in the following twenty-one days.

Hologic Stock Return Prediction: AI Predicts HOLX Average and Excess Return After a Fall or Rise
Hologic Stock Returns (Recent) against. Peers And S&P500
SPY’s five-day return was 0.4 percent, whereas HOLX’s was -3 percent.
HSIC had the best ten-day return of 3.8 percent, while HOLX had the lowest at -1.9 percent.
COO has the best return of 7.7%, while HSIC has the lowest return of -0.8%.

ADDITIONAL INFORMATION FOR YOU

Trefis Trefis Trefis Trefis Trefis Trefis Tre

While the HOLX stock may reach higher levels, the year 2020 has created a number of pricing discontinuities that may present trading opportunities. For example, the stock valuation for Mettler vs Abbott is quite counter-intuitive.
Here you may find all of Trefis’ Featured Analyses and Trefis Data./nRead More